Biotech · Public company · San Francisco, CA, US
Braveheart Bio, Inc.
Ticker BRVE · SEC CIK 0002131524
Track this companyFree. Adds Braveheart Bio, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials11 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availableNo recent cash burn filed
Pipeline2
- BHB-1893Phase 3 · Cardiomyopathy, Hypertrophic ObstructiveClinicalTrials.gov · fetched Nov 12, 2026
- MetoprololPhase 3 · Cardiomyopathy, Hypertrophic ObstructiveClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials1
- BHB-1893 Versus Metoprolol for Symptomatic Obstructive Hypertrophic CardiomyopathyPHASE3 · RECRUITING · started Sep 2, 2026ClinicalTrials.gov NCT07755904 · fetched Nov 12, 2026
SEC filings9
- 10-Q · 10-QSEC EDGAR · filed Nov 10, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Nov 10, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Nov 6, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed Sep 8, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Sep 8, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Aug 7, 2026 · fetched Nov 12, 2026
- 424B4 · S-1/ASEC EDGAR · filed Aug 6, 2026 · fetched Nov 12, 2026
- S-1/A · S-1/ASEC EDGAR · filed Jul 30, 2026 · fetched Nov 12, 2026
- S-1 · S-1SEC EDGAR · filed Jul 15, 2026 · fetched Nov 12, 2026